Asthma Drug Shows Promise Against Triple-Negative Breast Cancer and Resistant Tumors
An early study suggests that montelukast, a common asthma and allergy medication, may help the immune system fight hard-to-treat cancers like triple-negative breast cancer. By blocking inflammatory pathways, the drug could reduce tumors' ability to evade immune attacks, offering a new approach to cancer therapy.